Retail & Consumer Products Law Observer

Retail & Consumer Products Law Observer

Legal Insight for the Retail and Consumer Products Industry

David Ervin

David Ervin

David Ervin is a partner in the firm’s Washington, D.C. office and a member of the Advertising & Product Risk Management (APRM) and Intellectual Property groups. He focuses on the intersection of advertising and intellectual property law.

Read David's bio on Crowell & Moring's website

Subscribe to all posts by David Ervin

Join C&M and other Industry Experts for an Advertising for Associations Seminar

Posted in Advertising & Product Risk Management
On May 4, 2016, Crowell & Moring LLP will host a complimentary seminar on Advertising for Associations in their Washington, DC office. This afternoon program will focus on key issues affecting advertising communications and public relations strategies of major trade associations. It brings together leading trade association executives and lawyers, public relations specialists, and ad… Continue Reading

Make a Deal Like Mike – Michael Jordan Settles Two Right of Publicity Lawsuits

Posted in Advertising & Product Risk Management, IP/Brand Protection
Michael Jordan has settled two high-profile right of publicity lawsuits with two now-defunct grocery chains – Jewel Food Stores and Dominick’s Finer Foods.  In August, a jury awarded Jordan $8.9 million after a federal judge determined that Dominick’s violated Jordan’s rights under the Illinois Right of Publicity Act.  Jewel and Jordan were scheduled to start… Continue Reading

False-and-Misleading-Gram – FDA Issues Warning Letter Based on Kim Kardashian’s Instagram Selfie

Posted in Advertising & Product Risk Management
On Friday the U.S. Food and Drug Administration (FDA) sent a warning letter to Duchesnay, manufacturer of DICLEGIS, a morning sickness drug, based on a social media post by ubiquitous social media user, Kim Kardashian. Kardashian posted a picture of herself with the drug while touting its safety and efficacy. However, Kardashian failed to mention risk information… Continue Reading